Shifa International Hospitals Limited (PSX:SHFA)
Pakistan
· Delayed Price · Currency is PKR 408.39
-18.36 (-4.30%)
At close: Apr 24, 2025
PSX:SHFA Revenue
Shifa International Hospitals had revenue of 6.86B PKR in the quarter ending December 31, 2024, with 12.81% growth. This brings the company's revenue in the last twelve months to 25.45B, up 14.63% year-over-year. In the fiscal year ending June 30, 2024, Shifa International Hospitals had annual revenue of 23.55B with 19.57% growth.
Revenue (ttm)
25.45B
Revenue Growth
+14.63%
P/S Ratio
1.01
Revenue / Employee
4.76M
Employees
5,348
Market Cap
25.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | 14.22B | 1.96B | 16.02% |
| Jun 30, 2020 | 12.26B | 486.22M | 4.13% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 61.19B |
| Abbott Laboratories (Pakistan) | 68.18B |
| AGP Limited | 25.03B |
| Highnoon Laboratories | 24.63B |
| The Searle Company | 28.80B |
| Citi Pharma | 13.19B |
| Ferozsons Laboratories | 16.82B |
| Otsuka Pakistan | 3.69B |